RecruitingNCT07333027

Lonely in Depression

Effects of Loneliness in the Treatment of Depression


Sponsor

Friedrich-Alexander-Universität Erlangen-Nürnberg

Enrollment

200 participants

Start Date

Feb 5, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this prospective study is to better understand the link between loneliness and depression in the inpatient psychiatric treatment of depression. It aims to answer: Do lonely and not lonely persons benefit the same way from inpatient depression treatment? Is loneliness a clinical relevant factor in inpatient treatment of depression? What are the underlying biopsychosocial mechanisms? Participants will be asked to do some * self-report questionnaires * clinical interview * biosampling (blood, saliva, stool) at three main measurement timepoints (1. begin of inpatient treatment, 2. day of discharge, 3. three months after discharge).


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • primary diagnosis of depression according to ICD-10 (F32 or F33), as diagnosed by a physician or clinical psychologist in conjunction with the M.I.N.I. Mini-International Neuropsychiatric Interview diagnostic tools
  • inpatient elective or emergency admission to one of the two psychiatric clinics; - age over 18 years
  • sufficient understanding of spoken and written German
  • informed voluntary consent

Exclusion Criteria3

  • a current lack of capacity to provide consent (e.g., pronounced psychotic symptoms, stuporous depressive syndrome, and thought constriction to suicidality)
  • previous participation in the study
  • pregnancy or breastfeeding

Locations(2)

Friedrich-Alexander-Universität Erlangen-Nürnberg

Erlangen, Bavaria, Germany

Bezirkskliniken Mittelfranken, Clinic for Psychiatry, Addiction, Psychotherapie and Psychosomatic Medicine

Erlangen, Bavaria, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07333027


Related Trials